Taiwan Semiconductor proposes ramping up volume production upon completing the second stage of the Phase 1 fab.

Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares continue to trade higher after rising nearly 10% on Tuesday. Here's a look at ...

Mark Cuban didn't become a billionaire by relying on credit cards – they were more of a roadblock than a tool for him. Despite his massive success today, worth over $5.4 billion, Cuban learned early ...

The FDA has granted 510(k) clearance to Vivos Therapeutics' DNA oral appliance for treating moderate to severe obstructive sleep apnea and snoring in children aged 6-17.

Roku unveils Roku Ads Manager, a self-service platform designed to enhance CTV advertising for direct-to-consumer brands.

GSK released data from a Phase 3 trial evaluating the co-administration of Arexvy and Shingrix vaccines in adults 50+. The ...

Buying $100 In DDOG: If an investor had bought $100 of DDOG stock 5 years ago, it would be worth $311.99 today based on a ...

According to Benzinga Pro, Prospect Capital's peer group average for short interest as a percentage of float is 3.52%, which ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $6.78, a high estimate of $14.00, and a low estimate of $4.00. A 34.37% drop is evident in the current ...

Intuitive Machines, Inc. LUNR shares surged 52% to $8.19 after the company announced it was awarded a NASA Near Space Network contract for communication and navigation services, with a maximum ...

Discover how cannabis businesses can leverage global search trends from Semrush's new index to align strategies with consumer ...

Bristol Myers Squibb announces Phase 3 DAYBREAK trial data showing Zeposia (ozanimod) reduces brain volume loss in relapsing multiple sclerosis patients.